Working With CROs

Partner with our owned clinical sites, specialist populations, Clinical Pharmacology Units, and Human Challenge Unit to deliver fast, predictable early‑phase studies. Designed for CROs seeking reliable timelines and expanded capabilities  

Schedule a Call
hVIVO PK Consultancy Team

We help CROs deliver faster, more predictable, and higher‑quality early‑phase studies. With owned clinical sites, specialist populations, Clinical Pharmacology Units, and a dedicated Human Challenge Unit, we expand your capabilities while protecting your client relationships.  

Speak with our team

Working with CROs


We help CROs deliver faster, more predictable, and higher‑quality early‑phase studies. With owned clinical sites, specialist populations, Clinical Pharmacology Units, and a dedicated Human Challenge Unit, we expand your capabilities while protecting your client relationships.

Experience

With decades of operational delivery across first‑in-human programs, early clinical development, and infectious disease challenge studies, our teams bring practical, hands‑on expertise to CRO partnerships.

Expertise

Our physicians, project managers, and scientists have extensive experience in Phase I–III studies, PK/PD modelling, specialist participant populations, and viral challenge trial design and delivery.

Quality

We operate regulated, accredited units including Clinical Pharmacology Units and our Human Challenge Unit. All studies are conducted using validated processes, audited quality systems, and transparent delivery frameworks.

CRO Services

Owned Clinical Sites For Predictable Recruitment

  • Guaranteed bed capacity

  • Accurate timeline forecasting

  • Faster site readiness*

*No dependency on third‑party availability

Specialist Populations for Complex Studies

  • Renally impaired volunteers

  • Hepatically impaired volunteers

  • Pharmacogenetic populations

  • Targeted early‑phase cohorts

Phase I Clinical Pharmacology Units & Study types

  • FIH

  • SAD/MAD – PoC

  • PK/PD

  • Drug–drug interactions

  • BA/BE

  • Pharmacogenetics 

  • Biosimilars  

Human Challenge Unit for Infectious Disease Studies

  • GMP challenge agent manufacturing

  • In‑house virology, Immunology, Molecular and Bacterial laboratory

  • End‑to‑end project management

  • KOL‑level scientific engagement 

Fast Contracting & Rapid Start-Up

  • Streamlined templates

  • Dedicated commercial and legal pathways

  • Partner‑oriented processes 

FAQ

Get in touch with us
hVIVO operates strictly as an extension of a CRO’s delivery capability, not as a competitor. Our teams integrate into your existing operational model, supply specialist expertise where it’s needed, and maintain transparent communication throughout the partnership. This approach is backed by validated processes and audited quality systems, so CROs can subcontract with confidence while keeping full ownership of the sponsor relationship.

CROs partner with hVIVO to remove the recruitment and site-capacity risk from early-phase studies. Owned and operated clinical sites give guaranteed bed capacity, faster site readiness, and accurate timeline forecasting, with no dependency on third-party site availability. Combined with access to specialist and phenotyped volunteer populations, this lets CROs commit to sponsor timelines with far less operational risk.

hVIVO maintains access to renally impaired, hepatically impaired, and pharmacogenetic volunteer populations, along with targeted early-phase cohorts. These specialist groups let CROs take on more complex study designs without the lengthy site-feasibility delays that typically come with sourcing niche populations independently.

hVIVO’s Human Challenge Unit is a dedicated, regulated facility built specifically for infectious disease challenge trials. It offers GMP challenge agent manufacturing, in-house virology, immunology, molecular and bacterial laboratory services, end-to-end project management, and KOL-level scientific engagement — capabilities most CROs cannot replicate in-house.

Both. hVIVO can supply specific components — such as specialist populations, Clinical Pharmacology Unit delivery, or challenge study capability — or take on full end-to-end execution, depending on what a CRO needs to strengthen a specific proposal or delivery gap.
hVIVO supports fast contracting and rapid start-up through streamlined templates, dedicated commercial and legal pathways, and partner-oriented processes designed to reduce the lead time typically associated with subcontracting specialist trial work.
hVIVO operates five dedicated clinical and laboratory facilities across the UK, purpose-built for Phase I and human challenge studies, early clinical research, and specialist laboratory support — giving CRO partners a consistent, owned-site network rather than a patchwork of third-party sites.

Contact Us